Transcend Therapeutics
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
80 5th Ave Fl 18, New York, New York, 10...Revenue
<$5 MillionIndustry
About Transcend Therapeutics
Transcend Therapeutics is focused on developing rapid-acting treatments for neuropsychiatric diseases, particularly PTSD. Their lead product, TSND-201 (methylone), aims to provide effective solutions for patients who have not responded to traditional psychiatric medications. The company is dedicated to improving mental health outcomes and strives for a world free from neuropsychiatric disorders. They actively engage in research and clinical studies to advance their innovative therapies.Explore more
SIC Code 28,283NAICS Code 32,325Show moreTranscend Therapeutics Org Chart
Compare Similar Companies to Transcend Therapeutics
Compare insights from companies similar to Transcend Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Transcend Therapeutics Tech Stack
A closer look at the technologies used by Transcend Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Transcend Therapeutics
Sign Up For FreeTo access detailed company insights
Transcend Therapeutics is focused on developing rapid-acting treatments for neuropsychiatric diseases, particularly PTSD. Their lead product, TSND-201 (methylone), aims to provide effective solutions for patients who have not responded to traditional psychiatric medications. The company is dedicated to improving mental health outcomes and strives f... Read More